JAMA Neurology Viewpoint discusses migraine sex differences, research, treatments
Dr. Frank Porreca co-authored a Viewpoint article published July 24 in JAMA Neurology.
Research has shown a clear female predominance among migraine patients, which leads to a question: are there also sex differences in how effective migraine therapeutics are for women and men?
Frank Porreca, PhD, member of the University of Arizona Health Sciences Comprehensive Pain and Addiction Center, co-authored an article published in JAMA Neurology that reviews data showing that some current treatments for migraine are highly female-selective and discusses the clinical implications for doctors and patients.
Dr. Porreca, associate department head and professor of pharmacology at the UArizona College of Medicine – Tucson, is a leading expert about the sexually dimorphic nature of pain, migraine and current migraine therapeutics.
Migraine is the world’s most common neurological disorder, affecting approximately 1 billion people worldwide, the majority of whom are women. It is also one of the 10 most disabling medical illnesses on Earth, according to the World Health Organization.